Citius Pharmaceuticals, Inc. (CTXR): debt financing — Citius Pharma issues $1M unsecured note at 15% interest; CEO personally guarantees

Citius Pharmaceuticals, Inc.

$1M principal unsecured promissory note issued to Pagoda Resources on June 2, 2025.
Interest rate 15% per year, compounded monthly; mature date December 2, 2025.
Company may prepay at any time without penalty; note non-convertible.
CEO Leonard Mazur provides unconditional personal guaranty of full repayment.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Citius Pharmaceuticals, Inc. incurred loan of $1 million with PAGODA RESOURCES, INC at 15.00% per year, compounded monthly maturing December 2, 2025.

Instrument: loan
Principal: $1 million
Counterparty: PAGODA RESOURCES, INC
Rate: 15.00% per year, compounded monthly
Maturity: December 2, 2025
Event: incurrence

Exact text from the filing

On June 2, 2025, Citius Pharmaceuticals, Inc. (the “Company”) issued an unsecured promissory note for an aggregate principal amount of $1 million (the “Note”) to PAGODA RESOURCES, INC, a Pennsylvania corporation.

View on SEC.gov

Browse all debt financings →

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-050822

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.